JOHNSON AND JOHNSON FDA Approval NDA 019501

NDA 019501

JOHNSON AND JOHNSON

FDA Drug Application

Application #019501

Documents

Letter2005-06-23
Letter2005-06-23
Letter2015-04-29
Label2015-04-29
Letter2004-06-30
Label2005-06-23
Label2005-06-23
Review2011-09-22

Application Sponsors

NDA 019501JOHNSON AND JOHNSON

Marketing Status

Over-the-counter002
Over-the-counter003

Application Products

002SOLUTION;TOPICAL2%1ROGAINE (FOR MEN)MINOXIDIL
003SOLUTION;TOPICAL2%1ROGAINE (FOR WOMEN)MINOXIDIL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1988-08-17PRIORITY
LABELING; LabelingSUPPL2AP1989-09-19
EFFICACY; EfficacySUPPL3AP1991-08-13
LABELING; LabelingSUPPL4AP1990-03-23
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1990-02-12PRIORITY
LABELING; LabelingSUPPL6AP1990-02-23
LABELING; LabelingSUPPL7AP1990-10-05
LABELING; LabelingSUPPL8AP1994-04-08
LABELING; LabelingSUPPL9AP1992-09-24
LABELING; LabelingSUPPL10AP1993-07-28STANDARD
LABELING; LabelingSUPPL11AP1993-07-28STANDARD
EFFICACY; EfficacySUPPL12AP1996-02-09UNKNOWN
LABELING; LabelingSUPPL13AP1994-12-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1996-03-11PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1998-04-16PRIORITY
LABELING; LabelingSUPPL20AP2005-06-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2004-06-25PRIORITY
LABELING; LabelingSUPPL25AP2005-06-21STANDARD
LABELING; LabelingSUPPL29AP2015-04-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2016-05-24PRIORITY

Submissions Property Types

SUPPL5Null0
SUPPL14Null0
SUPPL16Null0
SUPPL20Null0
SUPPL24Null0
SUPPL29Null15
SUPPL30Null0

CDER Filings

JOHNSON AND JOHNSON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19501
            [companyName] => JOHNSON AND JOHNSON
            [docInserts] => ["",""]
            [products] => [{"drugName":"ROGAINE (FOR MEN)","activeIngredients":"MINOXIDIL","strength":"2%","dosageForm":"SOLUTION;TOPICAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"ROGAINE (FOR WOMEN)","activeIngredients":"MINOXIDIL","strength":"2%","dosageForm":"SOLUTION;TOPICAL","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"04\/27\/2015","submission":"SUPPL-29","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/019501Orig1s029lbl.pdf\"}]","notes":""},{"actionDate":"06\/21\/2005","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/019501s020,025lbl.pdf\"}]","notes":""},{"actionDate":"06\/21\/2005","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/019501s020,025lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ROGAINE (FOR MEN)","submission":"MINOXIDIL","actionType":"2%","submissionClassification":"SOLUTION;TOPICAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"},{"actionDate":"ROGAINE (FOR WOMEN)","submission":"MINOXIDIL","actionType":"2%","submissionClassification":"SOLUTION;TOPICAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2015-04-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.